Prot# 10630: Phz I/II Rndmzd, Dbl-Blnd, Dose Escalation Study of Safety, Tolerability, Pharmacokinetics & Efficacy of Subcutaneous Bay 50-4798 Admnstrtn in Ptnts w/HIV Infection on Highly Active Antiretroviral Therapy (HAART) Cmprd to Ptnts on HAART Alone

Project: Research project

Project Details

StatusFinished
Effective start/end date6/5/03 → 4/12/07

Funding

  • Inveresk Research, Inc. (10630 // 10630)
  • Bayer Corporation (10630 // 10630)